Dx dialogues: using molecular profiling to identify mutations in R/R AML
Dx dialogues: how AI might be used in the R/R AML space
Dx dialogues: the impact of next-generation sequencing on clinical utility
Dx dialogues: the importance of comprehensive testing in oncology
Dx dialogues: why staying current with technology is critical in oncology
Dx dialogues: versatile treatment options across the multiple myeloma landscape
Dx dialogues: the future of personalized ovarian response prediction
Dx dialogues: changes in treatment sequencing for metastatic breast cancer
Dx dialogues: HLA typing and patient selection with cutaneous melanoma
Dx dialogues: helping physicians identify patients for combination therapies with CAR-T
Identifying gene mutations is an important step in diagnosing AML and determining the best approach to treatment.
An overview of the therapies used when acute myeloid leukemia (AML) doesn’t respond to treatment or comes back after treatment.
While much of your cancer risk is out of your hands, you may be able to lower your odds by managing your weight.
An overview of hospice care, including the benefits it can offer and basic strategies for finding hospice care.
Strategies for working with multiple healthcare providers and specialists during the treatment of CAH.